INTERPACE BIOSCIENCES, INC. financial data

Symbol
IDXG on OTC
Location
Parsippany, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 130 % +25.2%
Quick Ratio 13.89 % +6.4%
Debt-to-equity -1,345 % -35.2%
Return On Equity -353 % -30.9%
Return On Assets 28.32 % -37.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,428,539 shares +0.54%
Common Stock, Shares, Outstanding 4,428,539 shares +0.54%
Entity Public Float 3,999,609 USD +5.6%
Common Stock, Value, Issued 407,000 USD +0.25%
Weighted Average Number of Shares Outstanding, Basic 4,425,000 shares +0.73%
Weighted Average Number of Shares Outstanding, Diluted 27,695,000 shares +5.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 41,914,000 USD -6.1%
Cost of Revenue 15,923,000 USD -2.4%
Research and Development Expense 694,000 USD +9.5%
Selling and Marketing Expense 10,894,000 USD -4.1%
General and Administrative Expense 9,836,000 USD +12.2%
Operating Income (Loss) 4,567,000 USD -39.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4,096,000 USD -32.7%
Income Tax Expense (Benefit) -11,000 USD -3.8%
Net Income (Loss) Attributable to Parent 3,799,000 USD -35.5%
Earnings Per Share, Basic 0 USD/shares -43.3%
Earnings Per Share, Diluted 0 USD/shares -1.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1,423,000 USD +1.6%
Accounts Receivable, after Allowance for Credit Loss, Current 5,966,000 USD -18.2%
Inventory, Net 1,104,000 USD -9.5%
Other Assets, Current 1,741,000 USD +2.2%
Assets, Current 9,130,000 USD +0.33%
Property, Plant and Equipment, Net 1,541,000 USD +14%
Operating Lease, Right-of-Use Asset 1,320,000 USD -13.8%
Other Assets, Noncurrent 45,000 USD 0%
Assets 12,036,000 USD -14.3%
Accounts Payable, Current 1,411,000 USD -17%
Employee-related Liabilities, Current 1,447,000 USD -14.2%
Liabilities, Current 5,945,000 USD +0.76%
Long-term Debt and Lease Obligation 1,748,000 USD -41.1%
Operating Lease, Liability, Noncurrent 864,000 USD -27.3%
Other Liabilities, Noncurrent 5,525,000 USD +5.7%
Liabilities 12,334,000 USD -31.6%
Retained Earnings (Accumulated Deficit) -233,462,000 USD +1.6%
Stockholders' Equity Attributable to Parent -298,000 USD +99.4%
Liabilities and Equity 12,036,000 USD -14.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1,235,000 USD
Net Cash Provided by (Used in) Financing Activities -1,500,000 USD -1.5%
Net Cash Provided by (Used in) Investing Activities -28,000 USD +56.9%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 4,569,333 shares +0.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -265,000 USD +61.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1,423,000 USD -32.7%
Deferred Tax Assets, Valuation Allowance 35,067,000 USD -5%
Operating Lease, Liability 1,283,000 USD -14.1%
Payments to Acquire Property, Plant, and Equipment 28,000 USD -56.9%
Lessee, Operating Lease, Liability, to be Paid 1,512,000 USD -19.6%
Property, Plant and Equipment, Gross 4,206,000 USD +26.2%
Operating Lease, Liability, Current 419,000 USD +37.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 550,000 USD +22.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 550,000 USD +22.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 229,000 USD -40.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 275,000 USD -50%
Deferred Tax Assets, Operating Loss Carryforwards 24,148,000 USD -3.4%
Preferred Stock, Shares Authorized 5,000,000 shares
Unrecognized Tax Benefits 877,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 275,000 USD
Amortization of Intangible Assets 900,000 USD -30.8%
Depreciation, Depletion and Amortization 95,000 USD +82.7%
Deferred Tax Assets, Net of Valuation Allowance 168,000 USD +7%
Share-based Payment Arrangement, Expense 104,000 USD -70%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares